Hangzhou Cheetah Cell Therapeutics Co., Ltd
2 clinical trials · Sponsor
◉ Watch Hangzhou Cheetah Cell Therapeutics Co., Ltd
| Record | Firm | Date |
|---|---|---|
| NKG2D CAR-NK & Ovarian Cancer (NCT05776355) | Hangzhou Cheetah Cell Therapeutics Co., Ltd | 2023-03-01 |
| NKG2D CAR-NK Cell Therapy in Patients With Relapsed or Refractory Acute Myeloid Leukemia (NCT05247957) | Hangzhou Cheetah Cell Therapeutics Co., Ltd | 2021-10-13 |
Track Hangzhou Cheetah Cell Therapeutics Co., Ltd automatically
Every clearance here is in the API, with alerts when new ones post.